PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Rosamultin Attenuates Acute Hypobaric Hypoxia-Induced Bone Injuries by Regulation of Sclerostin and Its Downstream Signals.

Rat / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32598190 ↗2020Reported benefit

Rosamultin Attenuates Acute Hypobaric Hypoxia-Induced Bone Injuries by Regulation of Sclerostin and Its Downstream Signals.

RatOtherPretreatment before hypobaric hypoxia exposure

Model: Acute hypobaric hypoxia simulating high altitude, causing bone damage and abnormal bone remodelling

Rosamultin pretreatment reduced hypobaric hypoxia induced oxidative stress and inflammation, improved bone metabolic abnormalities and rebalanced bone remodelling by suppressing sclerostin and activating Wnt/beta-catenin signalling.

Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.